CME passes final regulatory hurdle for NEX acquisition
CME Group has ticked off all of the regulatory approvals needed to forge ahead with its purchase of NEX Group, after the UK Competition and Markets Authority cleared the transaction on Wednesday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts
